{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:50:48Z","timestamp":1744213848395},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep07678","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T10:05:25Z","timestamp":1420711525000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Characterization and immunological activity of different forms of recombinant secreted Hc of botulinum neurotoxin serotype B products expressed in yeast"],"prefix":"10.1038","volume":"5","author":[{"given":"Bo","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DanYang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ShaoHong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YunZhou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZhiWei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,8]]},"reference":[{"key":"BFsrep07678_CR1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/infdis\/jit450","volume":"209","author":"N Dover","year":"2014","unstructured":"Dover, N., Barash, J. R., Hill, K. K., Xie, G. & Arnon, S. S. Molecular characterization of a novel botulinum neurotoxin type H gene. J Infect Dis 209, 192\u2013202 (2014).","journal-title":"J Infect Dis"},{"key":"BFsrep07678_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0968-0004(02)02177-1","volume":"27","author":"K Turton","year":"2002","unstructured":"Turton, K., Chaddock, J. A. & Acharya, K. R. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci 27, 552\u20138 (2002).","journal-title":"Trends Biochem Sci"},{"key":"BFsrep07678_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/DMP.0b013e318158c5fd","volume":"1","author":"ZF Dembek","year":"2007","unstructured":"Dembek, Z. F., Smith, L. A. & Rusnak, J. M. Botulism: cause, effects, diagnosis, clinical and laboratory identification and treatment modalities. Disaster Med Public Health Prep 1, 122\u201334 (2007).","journal-title":"Disaster Med Public Health Prep"},{"key":"BFsrep07678_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1615\/CritRevImmunol.v27.i4.20","volume":"27","author":"LA Smith","year":"2007","unstructured":"Smith, L. A. & Rusnak, J. M. Botulinum neurotoxin vaccines: past, present and future. Crit Rev Immunol 27, 303\u201318 (2007).","journal-title":"Crit Rev Immunol"},{"key":"BFsrep07678_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.mib.2012.05.009","volume":"15","author":"AP Karalewitz","year":"2012","unstructured":"Karalewitz, A. P. & Barbieri, J. T. Vaccines against botulism. Curr Opin Microbiol 15, 317\u201324 (2012).","journal-title":"Curr Opin Microbiol"},{"key":"BFsrep07678_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1586\/erv.13.37","volume":"12","author":"RP Webb","year":"2013","unstructured":"Webb, R. P. & Smith, L. A. What next for botulism vaccine development? Expert Rev Vaccines 12, 481\u201392 (2013).","journal-title":"Expert Rev Vaccines"},{"key":"BFsrep07678_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1586\/14760584.7.1.55","volume":"7","author":"LM Zarebski","year":"2008","unstructured":"Zarebski, L. M. et al. Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum. Expert Rev Vaccines 7, 55\u201374 (2008).","journal-title":"Expert Rev Vaccines"},{"key":"BFsrep07678_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1615\/CritRevImmunol.v30.i2.50","volume":"30","author":"KR Aoki","year":"2010","unstructured":"Aoki, K. R., Smith, L. A. & Atassi, M. Z. Mode of action of botulinum neurotoxins: current vaccination strategies and molecular immune recognition. Crit Rev Immunol 30, 167\u201387 (2010).","journal-title":"Crit Rev Immunol"},{"key":"BFsrep07678_CR9","doi-asserted-by":"publisher","first-page":"7313","DOI":"10.1016\/j.vaccine.2010.08.076","volume":"28","author":"JD Shearer","year":"2010","unstructured":"Shearer, J. D. et al. Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A\/B). Vaccine 28, 7313\u20138 (2010).","journal-title":"Vaccine"},{"key":"BFsrep07678_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.anaerobe.2014.06.003","volume":"28C","author":"GM Moreira","year":"2014","unstructured":"Moreira, G. M. et al. Production of recombinant botulism antigens: A review of expression systems. Anaerobe 28C, 130\u2013136 (2014).","journal-title":"Anaerobe"},{"key":"BFsrep07678_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1475-2859-4-33","volume":"4","author":"C Gurkan","year":"2005","unstructured":"Gurkan, C. & Ellar, D. J. Recombinant production of bacterial toxins and their derivatives in the methylotrophic yeast Pichia pastoris. Microb Cell Fact 4, 33 (2005).","journal-title":"Microb Cell Fact"},{"key":"BFsrep07678_CR12","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/nar\/19.7.1461","volume":"19","author":"MA Romanos","year":"1991","unstructured":"Romanos, M. A. et al. Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA. Nucleic Acids Res 19, 1461\u20137 (1991).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep07678_CR13","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/S0041-0101(98)00146-9","volume":"36","author":"LA Smith","year":"1998","unstructured":"Smith, L. A. Development of recombinant vaccines for botulinum neurotoxin. Toxicon 36, 1539\u201348 (1998).","journal-title":"Toxicon"},{"key":"BFsrep07678_CR14","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","volume":"82","author":"MP Byrne","year":"2000","unstructured":"Byrne, M. P. & Smith, L. A. Development of vaccines for prevention of botulism. Biochimie 82, 955\u201366 (2000).","journal-title":"Biochimie"},{"key":"BFsrep07678_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11033-011-0809-z","volume":"39","author":"YL Yang","year":"2012","unstructured":"Yang, Y. L., Chang, S. H., Gong, X., Wu, J. & Liu, B. Expression, purification and characterization of low-glycosylation influenza neuraminidase in alpha-1,6-mannosyltransferase defective Pichia pastoris. Mol Biol Rep 39, 857\u201364 (2012).","journal-title":"Mol Biol Rep"},{"key":"BFsrep07678_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.clim.2010.07.005","volume":"137","author":"YZ Yu","year":"2010","unstructured":"Yu, Y. Z. et al. Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F. Clin Immunol 137, 271\u201380 (2010).","journal-title":"Clin Immunol"},{"key":"BFsrep07678_CR17","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1016\/j.vaccine.2009.02.091","volume":"27","author":"YZ Yu","year":"2009","unstructured":"Yu, Y. Z. et al. The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate. Vaccine 27, 2816\u201322 (2009).","journal-title":"Vaccine"},{"key":"BFsrep07678_CR18","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1128\/IAI.01893-06","volume":"75","author":"E Ravichandran","year":"2007","unstructured":"Ravichandran, E. et al. Trivalent vaccine against botulinum toxin serotypes A, B and E that can be administered by the mucosal route. Infect Immun 75, 3043\u201354 (2007).","journal-title":"Infect Immun"},{"key":"BFsrep07678_CR19","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","volume":"66","author":"MP Byrne","year":"1998","unstructured":"Byrne, M. P., Smith, T. J., Montgomery, V. A. & Smith, L. A. Purification, potency and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate. Infect Immun 66, 4817\u201322 (1998).","journal-title":"Infect Immun"},{"key":"BFsrep07678_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1006\/prep.1998.0910","volume":"13","author":"KJ Potter","year":"1998","unstructured":"Potter, K. J. et al. Production and purification of the heavy-chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotrophic yeast Pichia pastoris. Protein Expr Purif 13, 357\u201365 (1998).","journal-title":"Protein Expr Purif"},{"key":"BFsrep07678_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1567-1364.2009.00498.x","volume":"9","author":"HL Zhao","year":"2009","unstructured":"Zhao, H. L. et al. Secretory expression of glycosylated and aglycosylated mutein of onconase from Pichia pastoris using different secretion signals and their purification and characterization. FEMS Yeast Res 9, 591\u20139 (2009).","journal-title":"FEMS Yeast Res"},{"key":"BFsrep07678_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.copbio.2006.06.010","volume":"17","author":"N Sethuraman","year":"2006","unstructured":"Sethuraman, N. & Stadheim, T. A. Challenges in therapeutic glycoprotein production. Curr Opin Biotechnol 17, 341\u20136 (2006).","journal-title":"Curr Opin Biotechnol"},{"key":"BFsrep07678_CR23","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1128\/IAI.01025-07","volume":"76","author":"MR Baldwin","year":"2008","unstructured":"Baldwin, M. R. et al. Subunit vaccine against the seven serotypes of botulism. Infect Immun 76, 1314\u20138 (2008).","journal-title":"Infect Immun"},{"key":"BFsrep07678_CR24","doi-asserted-by":"publisher","first-page":"6148","DOI":"10.1016\/j.vaccine.2009.08.022","volume":"27","author":"Y Yu","year":"2009","unstructured":"Yu, Y. et al. Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors. Vaccine 27, 6148\u201353 (2009).","journal-title":"Vaccine"},{"key":"BFsrep07678_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00253-008-1666-0","volume":"81","author":"HL Zhao","year":"2008","unstructured":"Zhao, H. L., Xue, C., Wang, Y., Yao, X. Q. & Liu, Z. M. Increasing the cell viability and heterologous protein expression of Pichia pastoris mutant deficient in PMR1 gene by culture condition optimization. Appl Microbiol Biotechnol 81, 235\u201341 (2008).","journal-title":"Appl Microbiol Biotechnol"},{"key":"BFsrep07678_CR26","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.vaccine.2013.03.046","volume":"31","author":"YZ Yu","year":"2013","unstructured":"Yu, Y. Z. et al. Potent tetravalent replicon vaccines against botulinum neurotoxins using DNA-based Semliki Forest virus replicon vectors. Vaccine 31, 2427\u201332 (2013).","journal-title":"Vaccine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep07678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07678","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T21:30:31Z","timestamp":1672954231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep07678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,7,15]]}},"alternative-id":["BFsrep07678"],"URL":"https:\/\/doi.org\/10.1038\/srep07678","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,8]]},"assertion":[{"value":"2 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7678"}}